Boston Scientific Announces Results For Second Quarter 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- CoreWeave stock drops on dilution fears and debt concerns
- SpaceX to acquire Grain Management's 800 MHz spectrum portfolio
- Oracle and these 6 stocks are newest addition to Mizuho Top Picks list
- Anthropic launches cyber defense program for infrastructure and open-source
- Devon Energy to sell Eagle Ford assets to Crescent Energy for $4.2B
Boston Scientific (BSX) PT Raised to $47 at Cowen
July 24, 2019 3:34 PM EDTCowen analyst Joshua Jennings raised the price target on Boston Scientific (NYSE: BSX) to $47.00 (from $42.00) while maintaining an Outperform rating.
The analyst commented, "While 2Q organic revenue growth of 6.3% was below the midpoint of guidance for 6%-7%, BSX has a steady flow... More
Boston Scientific (BSX) Tops Q2 EPS by 1c
July 24, 2019 6:32 AM EDTBoston Scientific (NYSE: BSX) reported Q2 EPS of $0.39, $0.01 better than the analyst estimate of $0.38. Revenue for the quarter came in at $2.63 billion versus the consensus estimate of $2.64 billion.
GUIDANCE:
Boston Scientific sees Q3 2019 EPS of $0.37-$0.39, versus the consensus of... More



